Kronos Bio, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACHL
|
Achilles Therapeutics plc | $1.02 | $37.06 M | -0.56 | 204 | $0 |
 ADXN
|
Addex Therapeutics Ltd | $9.77 | $13.74 M | -0.48 | 23 | $1.61 M |
 ASMB
|
Assembly Biosciences, Inc. | $15.08 | $78.73 M | -1.35 | 65 | $7.16 M |
 CCCC
|
C4 Therapeutics, Inc. | $5.70 | $320.64 M | -1.97 | 145 | $20.76 M |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $51.08 | $3.53 B | -11.86 | 290 | $4.01 M |
 CTMX
|
CytomX Therapeutics, Inc. | $1.19 | $127.79 M | 7.81 | 120 | $101.21 M |
 CYCN
|
Cyclerion Therapeutics, Inc. | $2.52 | $6.91 M | -0.56 | 1 | $0 |
 ERAS
|
Erasca, Inc. | $2.72 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $26.69 | $1.65 B | -11.47 | 97 | $0 |
 GBIO
|
Generation Bio Co. | $2.46 | $216.88 M | -1.28 | 174 | $5.90 M |
 GOSS
|
Gossamer Bio, Inc. | $0.98 | $124.06 M | -0.65 | 135 | $0 |
 INBX
|
Inhibrx Biosciences, Inc. | $15.65 | $241.02 M | -1.44 | 166 | $1.80 M |
 LRMR
|
Larimar Therapeutics, Inc. | $6.54 | $611.84 M | -9.99 | 42 | $0 |
 LYEL
|
Lyell Immunopharma, Inc. | $1.38 | $619.50 M | -2.7 | 224 | $130,000 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.26 | $19.53 M | -0.27 | 88 | $1.56 M |
 MRUS
|
Merus N.V. | $49.96 | $3.50 B | -19.38 | 172 | $43.95 M |
 NLTX
|
Neoleukin Therapeutics, Inc. | $3.49 | $8.20 M | -0.28 | 7 | $0 |
 NVCT
|
Nuvectis Pharma, Inc. | $6.23 | $116.38 M | -4.5 | 13 | $0 |
 NXTC
|
NextCure, Inc. | $1.36 | $38.88 M | -0.61 | 82 | $0 |
 REPL
|
Replimune Group, Inc. | $10.95 | $485.18 M | -2.44 | 331 | $0 |
 SPRO
|
Spero Therapeutics, Inc. | $1.33 | $75.85 M | 3.19 | 46 | $96.74 M |